-
The single author of this small pilot study concludes that 50 mg of 5-HTP taken three times a day for 4 weeks is ineffective against menopausal hot flashes. The paper is disappointing in many ways, however, and readers might question whether the actual reason behind the trial was indeed to test 5-HTP.
-
-
Health care clinicians and organizations likely will find that the new health care reform bill's positive features outweigh its drawbacks, experts say.
-
Surgical aortic valve replacement (SAVR) remains the gold standard treatment for calcific aortic stenosis (AS). However, AS is predominantly a disease of the elderly and, thus, many patients have significant comorbidities that make SAVR very high risk.
-
Little is known about the least common of left ventricular (LV) remodeling abnormalities, low ejection fraction (EF) with no cavity dilation or non-dilated cardiomyopathy.
-
The number of patients with implantable pacemakers and implantable defibrillators has increased markedly in recent years. Unfortunately, cardiac rhythm device (CRM)-related infections have also increased, and management of these infections is often problematic.
-
The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) study compared two different strategies for rate control in patients with permanent atrial fibrillation.
-
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.
-
The American Society of Echocardiography (ASE) has recommended that quantitative techniques be used to assess the severity of mitral regurgitation (MR) by echocardiography.
-
Although age is a risk factor for morbidity and mortality with cardiac surgery, chronologic age does not always reflect biological age. Although frailty has been shown to predict falls, hospitalization, institutionalization, and mortality in geriatric populations in the community, it has not been systematically studied in patients undergoing surgery.